Answers are grounded in this paper and cite their sources.
The rapid emergence of novel multidrug-resistant organisms coupled with the slow development of new antibiotics is of great concern. With the discovery of New Delhi metallo-beta-lactamase 1 (NDM-1)-producing Klebsiella pneumoniae, clinicians are faced with problems in the treatment of infections caused by this multidrug-resistant organism. Therapeutic experiences are limited. We share our experience of the successful treatment of a febrile neutropenic patient with NDM-1-producing K. pneumoniae bacteraemia.
No takes yet. Share an insight, caveat, or question.
Chien et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: